WATCH | AstraZeneca reports vaccine sales of nearly R4 billion

0:00
play article
Subscribers can listen to this article
AstraZeneca said its Covid-19 vaccine contributed $275 million (R3.95 billion) to first-quarter sales but shaved three cents per share from its earnings, as it posted better-than-expected results and forecast growth in the second half. 
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Rand - Dollar
14.17
-0.3%
Rand - Pound
19.93
-0.4%
Rand - Euro
17.17
-0.8%
Rand - Aus dollar
10.96
-0.5%
Rand - Yen
0.13
-0.6%
Gold
1,832.40
+0.3%
Silver
27.16
+0.3%
Palladium
2,918.00
+1.8%
Platinum
1,223.50
+1.1%
Brent Crude
67.05
-3.3%
Top 40
60,337
+0.2%
All Share
66,360
+0.3%
Resource 10
68,955
-0.8%
Industrial 25
83,189
+0.8%
Financial 15
12,609
+0.9%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Voting Booth
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, and I've gotten it.
21% - 1444 votes
No, I did not.
52% - 3607 votes
My landlord refused
27% - 1912 votes
Vote